文摘
The malfunction of a mutated GABAA receptor (α1β2γ2LK289M) in an inheritable form of epilepsy (GEFS+, generalized epilepsy with febrile seizures plus) in humans [Baulac, S., Huberfeld, G., Gourfinkel-An, I., Mitropoulou, G., Beranger, A., Prud8217;homme, J. F., Baulac, M., Brice, A., Bruzzone, R., and LeGuern, E. (2001) Nat. Genet. 28, 46−48] has been accounted for by a 5-fold decrease in the channel-opening equilibrium of the mutated receptor compared to the wild type [Ramakrishnan, L., and Hess, G. P. (2004) Biochemistry 43, 7534−7540]. Here we describe the mechanism by which the neurosteroid 3α, 21-dihydroxy-5α-pregnan-20-one (5α-THDOC) alleviates this malfunction of the mutated receptor transiently expressed in HEK293 cells. Two rapid reaction techniques, the cell-flow and the laser-pulse photolysis methods, were used in combination with whole-cell current recordings. 150-μM 5α-THDOC does not affect the rate constant for channel opening (kop) of 250 s−1 but does decrease the rate constant for channel closing (kcl) from 121 ± 11 s−1 to 56 ± 21 s−1. This results in an increase in the channel-opening equilibrium constant ((Φ−1 = kop/kcl) by a factor of about 2, leading to about 50% alleviation of the malfunction of the inheritable mutated (α1β2γ2LK289M) GABAA receptor linked to GEFS+.